Literature DB >> 11315844

Combination therapies with insulin in type 2 diabetes.

H Yki-Järvinen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11315844     DOI： 10.2337/diacare.24.4.758

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  62 in total

Review 1.  [New perspectives for the treatment of diabetes mellitus].

Authors:  P Roura Olmeda; M Mata Cases; J F Cano Pérez
Journal:  Aten Primaria       Date:  2005-03-31       Impact factor: 1.137

Review 2.  Diabetes in African Americans.

Authors:  M C Marshall
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

3.  Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Julie Ménard; Hélène Payette; Jean-Patrice Baillargeon; Pierre Maheux; Serge Lepage; Daniel Tessier; Jean-Luc Ardilouze
Journal:  CMAJ       Date:  2005-11-17       Impact factor: 8.262

Review 4.  Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.

Authors:  George Dailey; Karim Admane; Florence Mercier; David Owens
Journal:  Diabetes Technol Ther       Date:  2010-12       Impact factor: 6.118

Review 5.  Insulin therapy for type 2 diabetes.

Authors:  Afshin Sasali; Jack L Leahy
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

6.  Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes.

Authors:  S G H A Swinnen; J H DeVries
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

Review 7.  Diabetes: glycaemic control in type 2 (drug treatments).

Authors:  Kees J Gorter; Floris Alexander van de Laar; Paul G H Janssen; Sebastian T Houweling; Guy E H M Rutten
Journal:  BMJ Clin Evid       Date:  2012-10-11

8.  Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Authors:  Søren S Lund; Lise Tarnow; Merete Frandsen; Bente B Nielsen; Birgitte V Hansen; Oluf Pedersen; Hans-Henrik Parving; Allan A Vaag
Journal:  BMJ       Date:  2009-11-09

9.  A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.

Authors:  John P H Wilding; Paul Norwood; Caroline T'joen; Arnaud Bastien; James F List; Fred T Fiedorek
Journal:  Diabetes Care       Date:  2009-06-15       Impact factor: 19.112

Review 10.  Insulin therapy for type 2 diabetes.

Authors:  Sanne G Swinnen; Joost B Hoekstra; J Hans DeVries
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.